|
|
||||||||
Terry Fox Laboratory, British Columbia Cancer Agency, Vancouver, British Columbia, Canada
Thapsigargin, which elevates cytosolic calcium levels by inhibiting the sarcoplasmic/endoplasmic reticulum calcium-dependent ATPase, was tested for its ability to degranulate bone marrow-derived mast cells (BMMCs) from src homology 2-containing inositol phosphatase +/+ (SHIP+/+) and SHIP-/- mice. As was found previously with steel factor, thapsigargin stimulated far more degranulation in SHIP-/- than in SHIP+/+ BMMCs, and this was blocked with the phosphatidylinositol-3 (PI-3) kinase inhibitors, LY294002 and wortmannin. In contrast to steel factor, however, this heightened degranulation of SHIP-/- BMMCs was not due to a greater calcium influx into these cells, nor was the thapsigargin-induced calcium influx inhibited by LY294002, suggesting that the heightened thapsigargin-induced degranulation of SHIP-/- BMMCs was due to a PI-3 kinase-regulated step distinct from that regulating calcium entry. An investigation of thapsigargin-stimulated pathways in both cell types revealed that MAPK was heavily but equally phosphorylated. Interestingly, the protein kinase C inhibitor, bisindolylmaleimide (compound 3), totally blocked thapsigargin-induced degranulation in both SHIP+/+ and SHIP-/- BMMCs. As well, thapsigargin stimulated a PI-3 kinase-dependent, transient activation of protein kinase B, and this activation was far greater in SHIP-/- than in SHIP+/+ BMMCs. Consistent with this, thapsigargin was found to be a potent survival factor, following cytokine withdrawal, for both cell types and was more potent with SHIP-/- cells. These studies have both identified an additional PI-3 kinase-dependent step within the mast cell degranulation process, possibly involving 3-phosphoinositide-dependent protein kinase-1 and a diacylglycerol-independent protein kinase C isoform, and shown that the tumor-promoting activity of thapsigargin may be due to its activation of protein kinase B and subsequent promotion of cell survival.
This article has been cited by other articles:
![]() |
L. M. Sly, J. Kalesnikoff, V. Lam, D. Wong, C. Song, S. Omeis, K. Chan, C. W. K. Lee, R. P. Siraganian, J. Rivera, et al. IgE-Induced Mast Cell Survival Requires the Prolonged Generation of Reactive Oxygen Species J. Immunol., September 15, 2008; 181(6): 3850 - 3860. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Inoue, Y. Suzuki, T. Yoshimaru, and C. Ra Nitric oxide protects mast cells from activation-induced cell death: the role of the phosphatidylinositol-3 kinase-Akt-endothelial nitric oxide synthase pathway J. Leukoc. Biol., May 1, 2008; 83(5): 1218 - 1229. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. Textor, A. H. Licht, J. P. Tuckermann, R. Jessberger, E. Razin, P. Angel, M. Schorpp-Kistner, and B. Hartenstein JunB Is Required for IgE-Mediated Degranulation and Cytokine Release of Mast Cells J. Immunol., November 15, 2007; 179(10): 6873 - 6880. [Abstract] [Full Text] [PDF] |
||||
![]() |
W.-H. Leung and S. Bolland The Inositol 5'-Phosphatase SHIP-2 Negatively Regulates IgE-Induced Mast Cell Degranulation and Cytokine Production J. Immunol., July 1, 2007; 179(1): 95 - 102. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. Lessmann, M. Leitges, and M. Huber A redundant role for PKC-{varepsilon} in mast cell signaling and effector function Int. Immunol., May 1, 2006; 18(5): 767 - 773. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Gimborn, E. Lessmann, S. Kuppig, G. Krystal, and M. Huber SHIP Down-Regulates Fc{epsilon}R1-Induced Degranulation at Supraoptimal IgE or Antigen Levels J. Immunol., January 1, 2005; 174(1): 507 - 516. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Yasuoka, Y. Ihara, S. Ikeda, Y. Miyahara, T. Kondo, and S. Kohno Antiapoptotic Activity of Akt Is Down-regulated by Ca2+ in Myocardiac H9c2 Cells: EVIDENCE OF Ca2+-DEPENDENT REGULATION OF PROTEIN PHOSPHATASE 2Ac J. Biol. Chem., December 3, 2004; 279(49): 51182 - 51192. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. Kalinina, A. Agrotis, Y. Antropova, G. DiVitto, P. Kanellakis, G. Kostolias, O. Ilyinskaya, E. Tararak, and A. Bobik Increased Expression of the DNA-Binding Cytokine HMGB1 in Human Atherosclerotic Lesions: Role of Activated Macrophages and Cytokines Arterioscler. Thromb. Vasc. Biol., December 1, 2004; 24(12): 2320 - 2325. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. A. Windmiller and J. M. Backer Distinct Phosphoinositide 3-Kinases Mediate Mast Cell Degranulation in Response to G-protein-coupled Versus Fcepsilon RI Receptors J. Biol. Chem., March 28, 2003; 278(14): 11874 - 11878. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Leitges, K. Gimborn, W. Elis, J. Kalesnikoff, M. R. Hughes, G. Krystal, and M. Huber Protein Kinase C-{delta} Is a Negative Regulator of Antigen-Induced Mast Cell Degranulation Mol. Cell. Biol., June 15, 2002; 22(12): 3970 - 3980. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Kalesnikoff, N. Baur, M. Leitges, M. R. Hughes, J. E. Damen, M. Huber, and G. Krystal SHIP Negatively Regulates IgE + Antigen-Induced IL-6 Production in Mast Cells by Inhibiting NF-{kappa}B Activity J. Immunol., May 1, 2002; 168(9): 4737 - 4746. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. P. Scheid, M. Huber, J. E. Damen, M. Hughes, V. Kang, P. Neilsen, G. D. Prestwich, G. Krystal, and V. Duronio Phosphatidylinositol (3,4,5)P3 Is Essential but Not Sufficient for Protein Kinase B (PKB) Activation; Phosphatidylinositol (3,4)P2 Is Required for PKB Phosphorylation at Ser-473. STUDIES USING CELLS FROM SH2-CONTAINING INOSITOL-5-PHOSPHATASE KNOCKOUT MICE J. Biol. Chem., March 8, 2002; 277(11): 9027 - 9035. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Rossato, A. Nogara, M. Merico, A. Ferlin, A. Garolla, and C. Foresta Store-Operated Calcium Influx and Stimulation of Steroidogenesis in Rat Leydig Cells: Role of Ca2+-Activated K+ Channels Endocrinology, September 1, 2001; 142(9): 3865 - 3872. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. H. BROUGH, S. WU, D. CIOFFI, T. M. MOORE, M. LI, N. DEAN, and T. STEVENS Contribution of endogenously expressed Trp1 to a Ca2+-selective, store-operated Ca2+ entry pathway FASEB J, August 1, 2001; 15(10): 1727 - 1738. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. S. Manetz, C. Gonzalez-Espinosa, R. Arudchandran, S. Xirasagar, V. Tybulewicz, and J. Rivera Vav1 Regulates Phospholipase C{gamma} Activation and Calcium Responses in Mast Cells Mol. Cell. Biol., June 1, 2001; 21(11): 3763 - 3774. [Abstract] [Full Text] |
||||
![]() |
J. E. Damen, M. D. Ware, J. Kalesnikoff, M. R. Hughes, and G. Krystal SHIP's C-terminus is essential for its hydrolysis of PIP3 and inhibition of mast cell degranulation Blood, March 1, 2001; 97(5): 1343 - 1351. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Houlard, R. Arudchandran, F. Regnier-Ricard, A. Germani, S. Gisselbrecht, U. Blank, J. Rivera, and N. Varin-Blank Vav1 Is a Component of Transcriptionally Active Complexes J. Exp. Med., May 6, 2002; 195(9): 1115 - 1127. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |